The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Open accessAbstract
CC chemokines, a subfamily of 27 chemotactic cytokines, are a component of intercellular communication, which is crucial for the functioning of the tumor microenvironment. Although many individual chemokines have been well researched, there has been no comprehensive review presenting the role of all known human CC chemokines in the hallmarks of cancer, and this paper aims at filling this gap. The first part of this review discusses the importance of CCL1, CCL3, CCL4, CCL5, CCL18, CCL19, CCL20, CCL21, CCL25, CCL27, and CCL28 in cancer. Here, we discuss the significance of CCL2 (MCP-1), CCL7, CCL8, CCL11, CCL13, CCL14, CCL15, CCL16, CCL17, CCL22, CCL23, CCL24, and CCL26. The presentation of each chemokine includes its physiological function and then the role in tumor, including proliferation, drug resistance, migration, invasion, and organ-specific metastasis of tumor cells, as well as the effects on angiogenesis and lymphangiogenesis. We also discuss the effects of each CC chemokine on the recruitment of cancer-associated cells to the tumor niche (eosinophils, myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAM), tumor-associated neutrophils (TAN), regulatory T cells (Treg)). On the other hand, we also present the anti-cancer properties of CC chemokines, consisting in the recruitment of tumor-infiltrating lymphocytes (TIL).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–259 of 259
Sun, W., Li, W.-J., Wei, F., Wong, T., Lei, W., Zhu, X., Li, J., & Wen, W. (2016) · Oncotarget · doi:10.18632/oncotarget.9265 · Cited by 54
Wiesemann, A., Ketteler, J., Slama, A., Wirsdörfer, F., Hager, T., Roeck, K., Engel, D. R., Fischer, J. W., Aigner, C., Jendrossek, V., et al. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7458 · Cited by 54
Okada, N., Gao, J., Sasaki, A., Niwa, M., Okada, Y., Nakayama, T., Yoshie, O., Mizuguchi, H., Hayakawa, T., Fujita, T., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.013 · Cited by 53
Savino, B., Borroni, E. M., Torres, N. M., Proost, P., Struyf, S., Mortier, A., Mantovani, A., Locati, M., & Bonecchi, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029249 · Cited by 51
Son, K., Hwang, J.-S., Kwon, B. S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.037 · Cited by 51
Miyagaki, T., Sugaya, M., Murakami, T., Asano, Y., Tada, Y., Kadono, T., Okochi, H., Tamaki, K., & Sato, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3764 · Cited by 50
Vakili, J., Ständker, L., Detheux, M., Vassart, G., Forssmann, W., & Parmentier, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3406 · Cited by 49
Okada, N., Sasaki, A., Niwa, M., Okada, Y., Hatanaka, Y., Tani, Y., Mizuguchi, H., Nakagawa, S., Fujita, T., & Yamamoto, A. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700903 · Cited by 47
Yang, X., Lu, P., Ishida, Y., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21371 · Cited by 47
The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
Barbai, T., Fejôs, Z., Puskás, L. G., Tı́már, J., & Rásó, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5059 · Cited by 47
Chemotherapy Induces Macrophage ChemoattractantProtein-1 Production in Ovarian Cancer
Geller, M. A., Bui-Nguyen, T. M., Rogers, L. M., & Ramakrishnan, S. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181e5c442 · Cited by 47
Impact of tumor-derived CCL2 on T cell effector function
Vitiello, P. F., Shainheit, M. G., Allison, E. M., Adler, E. P., & Kurt, R. A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.12.009 · Cited by 46
Ding, M., He, S., & Yang, J. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0113 · Cited by 46
Cappello, P., Caorsi, C., Bosticardo, M., Angelis, S. D., Novelli, F., Forni, G., & Giovarelli, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403146 · Cited by 45
CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation
Trac, N. T., Chen, L., Zhang, A., Liao, C., Poon, C. J., Wang, J., Ando, Y., Joo, J., Garri, C., Shen, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.054 · Cited by 45
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
Nakanishi, T., Imaizumi, K., Hasegawa, Y., Kawabe, T., Hashimoto, N., Okamoto, M., & Shimokata, K. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0133-y · Cited by 44
Chen, D., Jiang, R., Mao, C., Shi, L., Wang, S., Yu, L., Hu, Q., Dai, D., & Xu, H. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.333 · Cited by 43
Guiducci, C., Carlo, E. D., Parenza, M., Hitt, M., Giovarelli, M., Musiani, P., & Colombo, M. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4026 · Cited by 41
The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis
Akram, I. G., Georges, R. B., Hielscher, T., Adwan, H., & Berger, M. R. (2015) · Tumor Biology · doi:10.1007/s13277-015-4089-4 · Cited by 41
Structural and Functional Characterization of CC Chemokine CCL14,
Blain, K. Y., Kwiatkowski, W., Zhao, Q., Fleur, D. L., Naik, C., Chun, T., Tsareva, T., Kanakaraj, P., Laird, M. W., Shah, R., et al. (2007) · Biochemistry · doi:10.1021/bi700936w · Cited by 41
Yoshimura, T., Imamichi, T., Weiss, J. M., Sato, M., Li, L., Matsukawa, A., & Wang, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00002 · Cited by 41
Identification of serum CCL15 in hepatocellular carcinoma
Li, Y., Wu, J., Zhang, W., Zhang, N., & Guo, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.494 · Cited by 40
Berencsi, K., Rani, P., Zhang, T., Gross, L. A., Mastrangelo, M. J., Meropol, N. J., Herlyn, D., & Somasundaram, R. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-33 · Cited by 39
Jia, X.-H., Du, Y., Mao, D., Wang, Z., He, Z., Qiu, J., Ma, X., Shang, W., Ding, D., & Tian, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4658 · Cited by 39
MCP2 activates NF‐κB signaling pathway promoting the migration and invasion of ESCC cells
Zhou, J. W., Zheng, S., Liu, T., Liu, Q., Chen, Y., Tan, D., Ma, R., & Lu, X. (2017) · Cell Biology International · doi:10.1002/cbin.10909 · Cited by 39
Grimm, S., Jennek, S., Singh, R., Enkelmann, A., Junker, K., Rippaus, N., Berndt, A., & Friedrich, K. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.001 · Cited by 37
Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
Arnold, J. M., Huggard, P. R., Cummings, M. C., Ramm, G. A., & Chenevix‐Trench, G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602596 · Cited by 37
CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs
Park, J. Y., Kang, Y. W., Choi, B. Y., Yang, Y. C., Cho, B. P., & Cho, W. G. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1298132 · Cited by 37
Gao, Y., Zhou, Z., Lu, S., Huang, X., Zhang, C., Jiang, R., Yao, A., Sun, B., & Wang, X. (2016) · Stem Cells · doi:10.1002/stem.2275 · Cited by 36
Münch, J., Ständker, L., Pöhlmann, S., Baribaud, F., Papkalla, A., Rosorius, O., Stauber, R. H., Sass, G., Heveker, N., Adermann, K., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.982-990.2002 · Cited by 34
CCL 11‐induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis
Xing, Y., Tian, Y., Kurosawa, T., Matsui, S., Touma, M., Yanai, T., Wu, Q., & Sugimoto, K. (2016) · Genes to Cells · doi:10.1111/gtc.12371 · Cited by 33
Cytokine profile of breast cell lines after different radiation doses
Bravatà, V., Minafra, L., Forte, G. I., Cammarata, F. P., Russo, G. I., Maggio, F. M. D., Augello, G., Lio, D., & Gilardi, M. C. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1362504 · Cited by 33
MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption
He, Z., He, J., Liu, Z., Xu, J., Yi, S., Liu, H., & Yang, J. (2014) · Biochimie · doi:10.1016/j.biochi.2014.07.017 · Cited by 32
Wang, H., Zhang, Q., Kong, H., Zeng, Y., Hao, M., Yu, T., Peng, J., Xu, Z., Chen, J., & Shi, H. (2014) · PubMed · Cited by 30
Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell.
Liu, L., Xie, F., Chang, K., Shang, W.-Q., Meng, Y., Yu, J., Li, H., Sun, Q., Yuan, M., Jin, L., et al. (2015) · Europe PMC (PubMed Central) · Cited by 29
Chen, Y., Luo, L., Urata, Y., Goto, S., & Li, T. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.037 · Cited by 29
PARP-1 controls NK cell recruitment to the site of viral infection
Shou, Q., Fu, H., Huang, X., & Yang, Y. (2019) · JCI Insight · doi:10.1172/jci.insight.121291 · Cited by 29
Li, J., Liu, H., Li, L., Wu, H., Wang, C., YAN, Z., Wang, Y., Su, C., Jin, H., ZHOU, F., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2217 · Cited by 28
MCP‐1 as a Potential Target to Inhibit the Bone Invasion by Oral Squamous Cell Carcinoma
Quan, J., Morrison, N. A., Johnson, N. W., & Gao, J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24849 · Cited by 25
Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas
Langenes, V., Svensson, H., Börjesson, L., Gustavsson, B. G., Bemark, M., Sjöling, Å., & Quiding‐Järbrink, M. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1472-0 · Cited by 25
Cappello, P., Fraone, T., Barberis, L., Costa, C., Hirsch, E., Elia, A. R., Caorsi, C., Musso, T., Novelli, F., & Giovarelli, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6143 · Cited by 25
CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
Li, Y., Yu, H., & Zhang, P. (2015) · Hepatology International · doi:10.1007/s12072-015-9683-4 · Cited by 25
Parody, T. R., & Stone, M. J. (2004) · Cytokine · doi:10.1016/j.cyto.2004.03.013 · Cited by 24
Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade Astrocytoma
Sharma, I., Singh, A., Sharma, K. C., & Saxena, S. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.5.1307 · Cited by 24
CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis
Yamaguchi, A., Nozawa, K., Fujishiro, M., Kawasaki, M., Suzuki, F., Takamori, K., Ogawa, H., Takasaki, Y., & Sekigawa, I. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0752-4 · Cited by 23
Quantification of the chemokines CCL17 and CCL22 in human colorectal adenocarcinomas
Hugander, A., Dimberg, J., Dienus, O., Löfgren, S., & Wågsäter, D. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.2.211 · Cited by 22
Human Eosinophils Produce and Release a Novel Chemokine, CCL23, in vitro
Matsumoto, K., Fukuda, S., Hashimoto, N., & Saito, H. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000327263 · Cited by 22
da Silva, J. M., Queiroz‐Junior, C. M., Batista, A. C., Rachid, M. A., Teixeira, M. M., & Silva, T. A. (2014) · PubMed · doi:10.14670/hh-29.387 · Cited by 21
CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis
Yamaguchi, A., Nozawa, K., Fujishiro, M., Kawasaki, M., Suzuki, F., Takamori, K., Ogawa, H., Takasaki, Y., & Sekigawa, I. (2013) · Modern Rheumatology · doi:10.3109/s10165-012-0752-4 · Cited by 21
Han, E. C., Lee, J., Ryu, S., & Choi, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.117 · Cited by 19
Increased CCL17 serum levels are associated with improved survival in advanced melanoma
Weide, B., Allgaier, N., Hector, A., Forschner, A., Leiter, U., Eigentler, T., Garbe, C., & Hartl, D. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1714-4 · Cited by 17
Struyf, S., Stoops, G., Coillie, E. V., Gouwy, M., Schutyser, E., Lenaerts, J., Fiten, P., Aelst, I. V., Proost, P., Opdenakker, G., et al. (2001) · Biochemistry · doi:10.1021/bi010224+ · Cited by 17
Shi, C., Yu, C.-H., Zhang, Y., Zhao, D., Chang, X.-H., & Wang, W. (2011) · PubMed · Cited by 16
Li, X., Li, D., Shi, Q., Huang, X., & Ju, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10074 · Cited by 14
Kim, J., Kim, Y. S., & Ko, J. (2010) · Cytokine · doi:10.1016/j.cyto.2009.12.010 · Cited by 11
Yang, J.-Y., Spanaus, K. S., & Widmer, U. (2000) · Cytokine · doi:10.1006/cyto.1999.0548 · Cited by 10
WEBER, K. L., Doucet, M., Shaner, A. C., Hsu, N. N., Huang, D. C. S., Fogel, J., & Kominsky, S. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040799 · Cited by 7
Caorsi, C., Cappello, P., Ceruti, P., Amici, A. R. D., Marchini, C., Novelli, F., Forni, G., & Giovarelli, M. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100411 · Cited by 6
Mauri, G., Chiodoni, C., Parenza, M., Arioli, I., Tripodo, C., & Colombo, M. P. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1486-7 · Cited by 5
Cited by
Harnessing cytokines and chemokines for cancer therapy
Propper, D. J., & Balkwill, F. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00588-9 · Cited by 989
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Macrophage Polarity and Disease Control
Kadomoto, S., Izumi, K., & Mizokami, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010144 · Cited by 318
Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., Prasad, S., Wang, P., Singh, A., & Singh, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02299-4 · Cited by 287
Wang, J., Zhou, X., Yu, P., Yao, J., Guo, P., Xu, Q., Zhao, Y., Wang, G., Li, Q., Zhu, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00886-2 · Cited by 28
Metadata
- Authors
- Korbecki, J., Kojder, K., Simińska, D., Bohatyrewicz, R., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-09
- Volume
- 21
- Issue
- 21
- Pages
- 8412
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3106021040
- Cited by
- 465
- References
- 259
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.